Market Access/ News/ News Intra-Cellular ends year with OK for schizophrenia drug lumateperone Phil Taylor Caplyta, depression, Intra-Cellular Therapies, schizophrenia 0 Comment US biotech Intra-Cellular Therapies’ has claimed an FDA approval for schizophrenia therapy lumateperone setting up the launch of Share X Intra-Cellular ends year with OK for schizophrenia drug lumateperone https://pharmaphorum.com/news/intra-cellular-ends-year-with-ok-for-schizophrenia-drug-lumateperone/
Caplyta, depression, Intra-Cellular Therapies, schizophrenia
0 Comment
